ArticleBMC genetics2006
The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases.
Article in BMC genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Validating a continental-scale groundwater diffuse pollution model using regional datasets.Environmental science and pollution research international · 2019Pooled it
- Exploring pathogenic SNPs and estrogen receptor alpha interactions in breast cancer: AnHeliyon · 2024Article
- Enhancing mass spectrometry imaging accessibility using convolutional autoencoders for deriving hypoxia-associated peptides from tumors.NPJ systems biology and applications · 2024Article
- Genetic risk assessment based on association and prediction studies.Scientific reports · 2023Article
- Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.Annals of medicine · 2022Article
- Genetic heterogeneity: Challenges, impacts, and methods through an associative lens.Genetic epidemiology · 2022Review
- A Machine Learning Tool to Predict the Antibacterial Capacity of Nanoparticles.Nanomaterials (Basel, Switzerland) · 2021Article
- Machine learning approaches for the prediction of bone mineral density by using genomic and phenotypic data of 5130 older men.Scientific reports · 2021Article
- Article
- Identification of early liver toxicity gene biomarkers using comparative supervised machine learning.Scientific reports · 2020Article
- A random forest based computational model for predicting novel lncRNA-disease associations.BMC bioinformatics · 2020Article
- Article
- Article
- SNP by SNP by environment interaction network of alcoholism.BMC systems biology · 2017Article
- Allelic Interactions amongFrontiers in plant science · 2017Article
- Comparing high-dimensional confounder control methods for rapid cohort studies from electronic health records.Journal of comparative effectiveness research · 2016Article
- Evaluation of potential novel variations and their interactions related to bipolar disorders: analysis of genome-wide association study data.Neuropsychiatric disease and treatment · 2016Article
- Research on single nucleotide polymorphisms interaction detection from network perspective.PloS one · 2015Article
- Big data analysis using modern statistical and machine learning methods in medicine.International neurourology journal · 2014Review
- Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genetic epidemiologists have taken the challenge to identify genetic polymorphisms involved in the development of diseases. Many have collected data on large numbers of genetic markers but are not familiar with available methods to assess their association with complex diseases. Statistical methods have been developed for analyzing the relation between large numbers of genetic and environmental predictors to disease or disease-related variables in genetic association studies. In this commentary we discuss logistic regression analysis, neural networks, including the parameter decreasing method (PDM) and genetic programming optimized neural networks (GPNN) and several non-parametric methods, which include the set association approach, combinatorial partitioning method (CPM), restricted partitioning method (RPM), multifactor dimensionality reduction (MDR) method and the random forests approach. The relative strengths and weaknesses of these methods are highlighted. Logistic regression and neural networks can handle only a limited number of predictor variables, depending on the number of observations in the dataset. Therefore, they are less useful than the non-parametric methods to approach association studies with large numbers of predictor variables. GPNN on the other hand may be a useful approach to select and model important predictors, but its performance to select the important effects in the presence of large numbers of predictors needs to be examined. Both the set association approach and random forests approach are able to handle a large number of predictors and are useful in reducing these predictors to a subset of predictors with an important contribution to disease. The combinatorial methods give more insight in combination patterns for sets of genetic and/or environmental predictor variables that may be related to the outcome variable. As the non-parametric methods have different strengths and weaknesses we conclude that to approach genetic association studies using the case-control design, the application of a combination of several methods, including the set association approach, MDR and the random forests approach, will likely be a useful strategy to find the important genes and interaction patterns involved in complex diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.